Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
grade F 108.2 1.04% 1.11
LLY closed down 1.59 percent on Wednesday, July 17, 2019, on 88 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical LLY trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.04%
Outside Day Range Expansion 1.04%
NR7 Range Contraction -0.57%
Lower Bollinger Band Walk Weakness -0.57%
Jack-in-the-Box Bearish Bearish Swing Setup -0.25%
Lower Bollinger Band Walk Weakness -0.25%
Inside Day Range Contraction -0.25%
Lower Bollinger Band Touch Weakness -0.25%
Expansion Breakdown Bearish Swing Setup -0.08%
Hammer Candlestick Bullish -0.08%

Older signals for LLY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Diabetes Pharmaceutical Products Neuroscience Schizophrenia Antibiotics Psychiatry Pulmonary Arterial Hypertension Psychiatric Diagnosis Animal Health Products Depression Major Depressive Disorder Attention Deficit Hyperactivity Disorder Wholesale Distributors Benign Prostatic Hyperplasia Obsessive Compulsive Disorder Osteoporosis Bipolar Disorder Cardiovascular Products Depressive Disorder Erectile Dysfunction Head And Neck Cancers Major Depressive Disorders Oncology Products Bulimia Nervosa High Cholesterol Psychology Respiratory And Other Diseases Testosterone Deficiency Treatment Resistant Depression
Is LLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 132.13
52 Week Low 88.17
Average Volume 3,933,378
200-Day Moving Average 116.587
50-Day Moving Average 114.3068
20-Day Moving Average 112.3405
10-Day Moving Average 110.886
Average True Range 2.3269
ADX 20.72
+DI 16.2401
-DI 37.9395
Chandelier Exit (Long, 3 ATRs ) 110.0893
Chandelier Exit (Short, 3 ATRs ) 112.1307
Upper Bollinger Band 117.7336
Lower Bollinger Band 106.9474
Percent B (%b) 0.01
BandWidth 9.601346
MACD Line -1.7678
MACD Signal Line -1.2813
MACD Histogram -0.4865
Fundamentals Value
Market Cap 112.98 Billion
Num Shares 1.05 Billion
EPS 2.31
Price-to-Earnings (P/E) Ratio 46.36
Price-to-Sales 4.03
Price-to-Book 6.30
PEG Ratio 1.77
Dividend 2.08
Dividend Yield 1.94%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 110.95
Resistance 3 (R3) 111.37 110.51 110.30
Resistance 2 (R2) 110.51 109.53 110.30 110.09
Resistance 1 (R1) 108.80 108.92 108.37 108.38 109.87
Pivot Point 107.94 107.94 107.73 107.73 107.94
Support 1 (S1) 106.23 106.96 105.80 105.81 104.31
Support 2 (S2) 105.37 106.35 105.16 104.09
Support 3 (S3) 103.66 105.37 103.88
Support 4 (S4) 103.24